← Insiders

DDD

Neutral signalScored 2026-09-23 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

Research, not advice.

À propos

3D Systems Corporation

Nom
3D Systems Corporation
Secteur
Technology
Industrie
Computer Hardware
Bourse
NYSE
Capitalisation
$505.1M
Employés
1,418
PDG
Jeffrey A. Graves
Site web
https://www.3dsystems.com
Marché
BGINBZAIGRRRLSAKMVISNNDM

3D Systems Corporation, operating globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions, specializes in delivering advanced 3D printing and digital manufacturing solutions. Its product portfolio includes a diverse array of 3D printers utilizing technologies like stereolithography, selective laser sintering, direct metal printing, multi-jet printing, color jet printing, extrusion, and SLA-based bioprinting. These systems are designed to convert digital input, sourced from 3D design software, CAD programs, or other digital modeling tools, into tangible physical components. Beyond hardware, the company formulates, produces, and distributes an extensive selection of print materials, encompassing plastics, nylon, metals, composites, elastomers, waxes, polymeric dental compounds, and biocompatible substances. Under its Geomagic brand, 3D Systems supplies a suite of digital design tools, which includes specialized software, scanners, and haptic devices. These offerings facilitate a broad spectrum of applications such as product design, simulation, mold and die creation, 3D scan-to-print workflows, reverse engineering, production machining, metrology, inspection, and comprehensive manufacturing process management. Proprietary software solutions are also a core offering. This includes 3D Sprint and 3DXpert, platforms engineered to streamline CAD data preparation and optimization, as well as overseeing additive manufacturing processes through features like automated support generation, build platform oversight, print simulation, and queue management. Additionally, Bioprint Pro serves as a dedicated software solution empowering researchers to design and execute reproducible bioprinting experiments. The corporation further extends its value proposition through a range of services, including maintenance, technical training, contract manufacturing, software support, and precision healthcare solutions. Its clientele spans a wide spectrum, from small and medium-sized enterprises to large corporations, across numerous sectors such as medical, dental, automotive, aerospace, defense, technology, durable goods, government, jewelry, electronics, education, consumer products, energy, and biotechnology. Sales and distribution are managed via a direct sales force, strategic channel partners, and authorized distributors. Established in 1986, 3D Systems Corporation maintains its corporate headquarters in Rock Hill, South Carolina.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 158 186 titres (~528 065,30 $ US)

Insiders
GRAVES JEFFREY A
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$635,465

Avg sell (VWAP, 90d window) $3.38 vs last close $3.57 (+5.7%)

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
2026-09-17
Liquidity
Thin $8,193,032/day · 20d vol
Last synced
2026-09-25 21:10:20 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-09-17 GRAVES JEFFREY A Sell · S 42,686 $3.55 $151,535 Form 4
2026-09-17 Nordstrom Phyllis B Sell · S 30,000 $3.58 $107,400 Form 4
2026-08-20 GRAVES JEFFREY A Sell · S 115,500 $3.26 $376,530 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2021-01-27Garret GravesSale (Full)$1,001 - $15,000

Signal

Neutral signalScored 2026-09-23 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

DDD presents a mixed but ultimately weak profile: while the company has returned to accounting profitability in 2025, persistent negative operating cash flow and a deeply negative interest coverage ratio undermine the…

The first sentence of the analysis written for DDD on 2026-09-23 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Congress Unavailable or mixed. No purchase disclosures in the stored window
  • Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
  • Timing Supports a bullish reading. Interesting trend — weekly bias up
  • Financial indicators Unavailable or mixed. Current ratio 2.87 · operating margin -25% — readings disagree

Suggested stop 3.07, nearest stored support minus 0.5 ATR(14.0% under the last close). Reward/risk to the next stored resistance is 0.20. Wait — that reward/risk is under 2. Research, not advice. Not an order.

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin33.9%37.3%40.2%39.8%42.8%
Ebit Margin14.2%-56.2%-73.6%-21.9%52.3%
Ebitda Margin19.7%-48.7%-66.7%-15.2%57.9%
Operating Profit Margin-24.6%-63.0%-83.2%-21.7%-5.4%
Pretax Profit Margin11.6%-57.6%-74.5%-22.5%51.9%
Continuous Operations Profit Margin7.7%-58.1%-74.4%-22.9%52.3%
Net Profit Margin7.7%-58.1%-74.3%-22.8%52.3%
Bottom Line Profit Margin8.4%-58.1%-74.3%-22.8%52.3%
Current Ratio2.8743.0834.2655.4955.796
Quick Ratio1.8172.2313.2314.5875.274
Solvency Ratio0.184-0.516-0.586-0.1250.505
Cash Ratio0.7931.2322.2522.5574.436
Price To Earnings Ratio9.316-1.691-2.228-7.7088.221
Price To Earnings Growth Ratio-0.0850.053-0.0110.056-0.027
Forward Price To Earnings Growth Ratio-0.0850.053-0.0110.056-0.027
Price To Earnings Diluted Ratio9.316-1.691-2.228-7.7088.447
Price To Earnings Diluted Growth Ratio-0.0850.053-0.0110.056-0.028
Price To Book Ratio0.9252.4551.9341.2613.142
Price To Sales Ratio0.5750.9831.6911.7584.299
Price To Free Cash Flow Ratio-2.274-7.089-7.649-10.40290.154
Price To Operating Cash Flow Ratio-2.532-9.635-10.225-13.50854.968
Debt To Assets Ratio0.3040.4700.4030.3460.324
Debt To Equity Ratio0.6591.6240.9360.6670.597
Debt To Capital Ratio0.3970.6190.4830.4000.374
Long Term Debt To Capital Ratio0.2640.5460.4280.3750.347
Financial Leverage Ratio2.1713.4562.3211.9291.839
Working Capital Turnover Ratio1.5001.1430.8390.7001.189
Operating Cash Flow Ratio-0.728-0.323-0.548-0.4610.270
Operating Cash Flow Sales Ratio-0.227-0.102-0.165-0.1300.078
Free Cash Flow Operating Cash Flow Ratio1.1131.3591.3371.2990.610
Debt Service Coverage Ratio6.742-84.366-98.442-29.920153.425
Interest Coverage Ratio-18.466-108.190-122.994-41.629-14.132
Short Term Operating Cash Flow Coverage Ratio-22.2690.0000.0000.0000.000
Operating Cash Flow Coverage Ratio-0.554-0.157-0.202-0.1400.096
Capital Expenditure Coverage Ratio-8.832-2.784-2.969-3.3492.562
Dividend Paid And Capex Coverage Ratio-8.832-2.784-2.969-3.3492.562
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple3.739-2.556-2.742-12.9096.619

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 33.9% ▼-3.4% ▼-5.0%
Ebit Margin 14.1% ▲70.4% ▲31.2%
Ebitda Margin 19.7% ▲68.4% ▲30.3%
Operating Profit Margin -24.6% ▲38.4% ▲15.0%
Pretax Profit Margin 11.6% ▲69.1% ▲29.8%
Continuous Operations Profit Margin 7.7% ▲65.8% ▲26.8%
Net Profit Margin 7.7% ▲65.8% ▲26.8%
Bottom Line Profit Margin 8.5% ▲66.5% ▲27.3%
Current Ratio 2.874 ▼-0.209 ▼-1.429
Quick Ratio 1.817 ▼-0.413 ▼-1.611
Solvency Ratio 0.184 ▲0.700 ▲0.292
Cash Ratio 0.793 ▼-0.439 ▼-1.461
Price To Earnings Ratio 9.316 ▲11.007 ▲8.134
Price To Earnings Growth Ratio -0.085 ▼-0.138 ▼-0.082
Forward Price To Earnings Growth Ratio -0.085 ▼-0.138 ▼-0.082
Price To Earnings Diluted Ratio 9.316 ▲11.007 ▲8.089
Price To Earnings Diluted Growth Ratio -0.085 ▼-0.138 ▼-0.082
Price To Book Ratio 0.925 ▼-1.530 ▼-1.018
Price To Sales Ratio 0.575 ▼-0.408 ▼-1.286
Price To Free Cash Flow Ratio -2.274 ▲4.815 ▼-14.822
Price To Operating Cash Flow Ratio -2.532 ▲7.104 ▼-6.345
Debt To Assets Ratio 0.304 ▼-0.166 ▼-0.066
Debt To Equity Ratio 0.659 ▼-0.964 ▼-0.237
Debt To Capital Ratio 0.397 ▼-0.222 ▼-0.057
Long Term Debt To Capital Ratio 0.264 ▼-0.282 ▼-0.128
Financial Leverage Ratio 2.171 ▼-1.285 ▼-0.172
Working Capital Turnover Ratio 1.500 ▲0.357 ▲0.426
Operating Cash Flow Ratio -0.728 ▼-0.405 ▼-0.370
Operating Cash Flow Sales Ratio -0.227 ▼-0.125 ▼-0.118
Free Cash Flow Operating Cash Flow Ratio 1.113 ▼-0.246 ▼-0.030
Debt Service Coverage Ratio 6.742 ▲91.108 ▲17.254
Interest Coverage Ratio -18.466 ▲89.724 ▲42.616
Short Term Operating Cash Flow Coverage Ratio -22.269 ▼-22.269 ▼-17.815
Operating Cash Flow Coverage Ratio -0.554 ▼-0.397 ▼-0.363
Capital Expenditure Coverage Ratio -8.832 ▼-6.048 ▼-5.758
Dividend Paid And Capex Coverage Ratio -8.832 ▼-6.048 ▼-5.758
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 3.739 ▲6.295 ▲5.309

Key metrics

MetricTrend20252024202320222021
Market cap$222.4M$432.5M$825.1M$945.9M$2.65B
Enterprise value$285.2M$547.2M$892.9M$1.06B$2.36B
EV / Sales0.74x1.24x1.83x1.97x3.83x
EV / Op. cash flow-3.25x-12.19x-11.06x-15.11x49.01x
EV / Free cash flow-2.92x-8.97x-8.28x-11.64x80.38x
EV / EBITDA3.74x-2.56x-2.74x-12.91x6.62x
Net debt / EBITDA0.82x-0.54x-0.21x-1.37x-0.81x
Current ratio2.87x3.08x4.26x5.50x5.80x
Income quality-2.94x0.18x0.22x0.57x0.15x
Graham number$3———$20
Graham net-net-$0-$1-$1$0$2
Tax burden66.8%100.9%99.8%101.6%100.8%
Interest burden81.7%102.4%101.3%102.4%99.3%
Working capital$226.1M$289.7M$480.6M$682.4M$853.7M
Invested capital$360.7M$433.1M$794.5M$1.26B$1.35B
Return on assets5.7%-42.0%-36.6%-8.5%20.8%
Operating ROA-16.9%-34.7%-33.3%-7.8%-2.9%
Return on tangible assets6.1%-44.4%-44.7%-12.6%27.8%
Return on equity12.4%-145.1%-85.0%-16.4%38.2%
Return on invested capital-15.2%-57.7%-47.4%-9.0%-2.4%
Return on capital employed-23.8%-59.1%-48.1%-9.0%-2.4%
Earnings yield13.4%-59.1%-44.0%-13.0%12.2%
Free cash flow yield-44.0%-14.1%-13.1%-9.6%1.1%
Capex / Op. cash flow-11.3%-35.9%-33.7%-29.9%39.0%
Capex / Depreciation46.2%48.4%75.4%58.0%54.3%
Capex / Sales2.6%3.7%5.6%3.9%3.1%
SG&A / Sales41.7%47.7%43.1%45.4%37.0%
R&D / Sales16.8%19.6%18.3%16.2%11.2%
Stock comp / Sales2.5%4.2%4.8%7.9%9.0%
Intangibles / Total assets6.2%5.4%18.0%32.9%25.3%
Days sales outstanding85d84d76d64d63d
Days payables outstanding58d55d62d61d60d
Operating cycle266d241d266d219d160d
Cash conversion cycle207d186d204d158d100d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-48.6%EV / Sales ▼-40.7%EV / EBITDA ▲+246.3%EV / Op. cash flow ▲+8.944Earnings yield ▲+0.725
Profitability
Return on equity ▲+1.575Return on assets ▲+0.477Return on invested capital ▲+0.425Return on capital employed ▲+0.353Operating ROA ▲+0.178Income quality ▼-3.115Tax burden ▼-0.341
Efficiency
Days sales outstanding ▲+0.571Days payables outstanding ▲+2.892Operating cycle ▲+24.774Cash conversion cycle ▲+21.882Capex / Sales ▼-0.011R&D / Sales ▼-0.028
Balance-sheet strength
Current ratio ▼-0.209Net debt / EBITDA ▲+1.360Working capital ▼-63650000.000Invested capital ▼-72458000.000Intangibles / Total assets ▲+0.008

Change over 5 years

Valuation
Market cap ▼-91.6%EV / Sales ▼-80.8%EV / EBITDA ▼-43.5%EV / Op. cash flow ▼-52.254Earnings yield ▲+0.013Graham number ▼-16.908
Profitability
Return on equity ▼-0.258Return on assets ▼-0.151Return on invested capital ▼-0.128Return on capital employed ▼-0.214Operating ROA ▼-0.140Income quality ▼-3.089Tax burden ▼-0.340
Efficiency
Days sales outstanding ▲+21.557Days payables outstanding ▼-1.282Operating cycle ▲+106.189Cash conversion cycle ▲+107.471Capex / Sales ▼-0.005R&D / Sales ▲+0.056
Balance-sheet strength
Current ratio ▼-2.922Net debt / EBITDA ▲+1.629Working capital ▼-627641000.000Invested capital ▼-988101000.000Intangibles / Total assets ▼-0.191

Employee count

Peer market caps

Recent news